JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2014-01-23 zhangjqtmmu

Received date: 12-9-2013
Revised date: 26-11-2013
Accepted date: 27-12-2013

389 0

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2014-01-23 zhangjqtmmu

审稿速度:2.0 | 投稿命中率:75.0
经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。

343 0

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2013-03-20 zhangjqtmmu

四个月不到的时间，就等着排版付印，也还算快吧

385 0

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2013-03-20 zhang

四个月不到的时间，就等着排版付印，也还算快吧

408 0

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2013-03-20 匿名用户

Received at Editorial Office: 24 Nov 2012

Article revised: 6 Feb 2013

Article accepted for publication: 19 Feb 2013

Received at Elsevier: 21 Feb 2013

Journal publishing agreement sent to author: 26 Feb 2013

Offprint order form sent to author: 6 Mar 2013

PDF offprint: Yes

Proofs available: 10 Mar 2013

Proofs returned: 14 Mar 2013

Journal publishing agreement returned: 7 Mar 2013

Accepted manuscript available online: view accepted manuscript online

Offprint order form sent to author: 6 Mar 2013

350 0

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2013-03-20 匿名用户

审稿速度:2.0
经验分享：投了一篇综述接受了，不好说别的，这是第一篇

296 0

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2012-12-11 匿名用户

投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。

338 0

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2012-07-26 ms3555409846413331

7月20号投的，很忐忑，翘首期盼中~~~

35 0

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2012-07-23 匿名用户

植物方面的与类固醇有关的可以投这个杂志吗？

316 0

[GetPortalCommentsPageByObjectIdResponse(id=500800, encodeId=03bd500800c3, content=Received date: 12-9-2013 Revised date: 26-11-2013 Accepted date: 27-12-2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:42:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500799, encodeId=9b14500e9997, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：上一篇稿件是综述，这一篇是论著，都接受了。论著中研究方法是最简单的免疫组化，个人觉得立意新颖是接受的主要原因，其实个人都觉得太简单了点。一审好像是大修，修回后直接接受，连语言都没让改，颇出乎意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Thu Jan 23 09:31:00 CST 2014, time=2014-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494477, encodeId=0bfe4944e7d4, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa4147444, createdName=zhangjqtmmu, createdTime=Wed Mar 20 22:30:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494476, encodeId=7a9a4944e659, content=四个月不到的时间，就等着排版付印，也还算快吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhang, createdTime=Wed Mar 20 22:26:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494475, encodeId=ea2f4944e5b3, content=Received at Editorial Office: 24 Nov 2012 Article revised: 6 Feb 2013 Article accepted for publication: 19 Feb 2013 Received at Elsevier: 21 Feb 2013 Journal publishing agreement sent to author: 26 Feb 2013 Offprint order form sent to author: 6 Mar 2013 PDF offprint: Yes Proofs available: 10 Mar 2013 Proofs returned: 14 Mar 2013 Journal publishing agreement returned: 7 Mar 2013 Accepted manuscript available online: view accepted manuscript online Offprint order form sent to author: 6 Mar 2013, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:24:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494474, encodeId=7a204944e4bb, content=审稿速度:2.0 经验分享：投了一篇综述接受了，不好说别的，这是第一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Mar 20 22:19:00 CST 2013, time=2013-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492831, encodeId=c33549283101, content=投了快一个月了还在under review 祈祷啊希望有好结果啊下周应该就会出接触了紧张。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Dec 11 03:41:00 CST 2012, time=2012-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=820821, encodeId=be7682082149, content=7月20号投的，很忐忑，翘首期盼中~~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4b55414010, createdName=ms3555409846413331, createdTime=Thu Jul 26 11:04:00 CST 2012, time=2012-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=489775, encodeId=c782489e75d9, content=植物方面的与类固醇有关的可以投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=316, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 23 17:15:00 CST 2012, time=2012-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483496, encodeId=dfe5483496a4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：文章编辑非常友好，反馈速度很快， 审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。 英式英语用法, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jul 16 14:56:00 CST 2011, time=2011-07-16, status=1, ipAttribution=)]

2011-07-16 xzw113

审稿速度:1.0 | 投稿命中率:75.0
经验分享：文章编辑非常友好，反馈速度很快，
审稿人意见比较中肯，适合中国研究人员发表，对文章的语法要求较高。
英式英语用法

386 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务